NewAmsterdam Pharma Company N.V

Historical 13F Holders

Symbol
NAMS
CUSIP
N62509109
All holders as of
Q4 2025
Type
Equity
Class
ORDINARY SHARES
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 195 118 M $4.13 B
2025 Q3 147 123 M $3.49 B
2025 Q2 140 116 M $2.11 B
2025 Q1 136 111 M $2.28 B
2024 Q4 144 98.6 M $2.53 B
2024 Q3 107 77.1 M $1.28 B
2024 Q2 98 72.3 M $1.39 B
2024 Q1 81 72.5 M $1.71 B
2023 Q4 38 63.6 M $710 M
2023 Q3 37 50.2 M $464 M
2023 Q2 31 48.8 M $581 M
2023 Q1 21 33.3 M $445 M
2022 Q4 15 33.5 M $362 M